Charles Schwab Investment Management Inc Shattuck Labs, Inc. Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 20,906 shares of STTK stock, worth $41,393. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,906
Previous 114,139
81.68%
Holding current value
$41,393
Previous $108,000
85.19%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding STTK
# of Institutions
64Shares Held
30.4MCall Options Held
36KPut Options Held
0-
Prosight Management, LP Dallas, TX6.64MShares$13.1 Million1.42% of portfolio
-
Redmile Group, LLC San Francisco, CA5.54MShares$11 Million0.53% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.68MShares$9.26 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$4.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.15MShares$4.25 Million0.0% of portfolio
About Shattuck Labs, Inc.
- Ticker STTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,382,000
- Market Cap $83.9M
- Description
- Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...